On August 21, 2024, Professor Fiorella Guadagni, a renowned expert in Clinical Biochemistry and Molecular Biology from San Raffaele Roma…
REVERT - taRgeted thErapy for adVanced colorEctal canceR paTients
REVERT’s Breakthrough in AI-Based Oncology Decision Support Featured in Open Access Government
The REVERT project has been recently featured in the prestigious Open Access Government digital publication. This recognition highlights the innovative…
REVERT promoted on the EU Research and Innovation community platform CORDIS
CORDIS, as part of the EC’s strategy for the dissemination and exploitation of research results of projects supported by EU…
Use of RNA profiles to predict therapeutic response to standard treatment and for the identification of potentially novel therapeutic options in colorectal adenocarcinoma
Use of RNA profiles to predict therapeutic response to standard treatment and for the identification of potentially novel therapeutic options…
REVERT project objectives towards fighting against colorectal cancer showcased by PROTV, one of the most important media stations from Romania
Prof. Cipriana Stefanescu, the president of IMAGO-MOL’s Scientific Council and scientific coordinator of REVERT project and prof. Adrian Iftene, MedTech…
The Revert project at the biggest science week in the Region of Murcia
Horacio Pérez Sánchez, researcher at the Catholic University of Murcia (UCAM), partner of REVERT, participated last October in the Science…
REVERT promoted by the EU Research magazine
EU Research is an effective, accessible and widely distributed platform for the dissemination of scientific research, the progress of which…
Interesting interview of Prof. Mario Roselli about the opportunity of the Revert project for the colorectal cancer patients
Prof. Mario Roselli, Director of the Medical Oncology Unit and Full Professor at the University Hospital Tor Vergata was interviewed…
The importance of REVERT in Spain: the dynamic Spanish partners promote the project activities and future outcomes
From April 24 to 27, 2023, UCAM Universidad Católica de Murcia held in its facilities the VII UCAM International Staff…
Launch of the REVERT project clinical study: research and innovation to support colorectal cancer patients
The REVERT (taRgeted thErapy for adVanced colorEctal canceR paTients) project, financedby the European Horizon 2020 Programme and led by the…
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 848098”.